Form 4: Arvinas Director Receives Stock Options and RSUs

Arvinas, Inc. Director Laurie Smaldone Alsup was granted stock options and restricted stock units on June 24, 2026, with vesting conditions tied to service and annual meetings.

Summary

• Laurie Smaldone Alsup, a Director at Arvinas, Inc., received a grant of 15,527 Restricted Stock Units (RSUs) on June 24, 2026. These RSUs represent a contingent right to receive one share of common stock upon settlement, with no consideration required.
• Additionally, Alsup was granted stock options to purchase 22,714 shares of common stock at an exercise price of $8.05 per share, also on June 24, 2026.
• Both the RSUs and the stock options are subject to vesting conditions. They will vest in full on the earlier of June 24, 2027, or immediately prior to the first annual stockholders' meeting after the grant date, provided Alsup continues her service with the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity grants to a director rather than significant financial or strategic developments.

Positives

• Director Laurie Smaldone Alsup received equity awards, indicating continued investment and alignment with the company's performance.
• The grant of RSUs and stock options suggests management's confidence in future growth and value creation.
• Vesting conditions tied to continued service and annual meetings align executive incentives with long-term company success and shareholder interests.

Negatives

• The filing does not contain any negative financial results or operational setbacks.

Risks

• The value of the RSUs and stock options is contingent on the company's future stock performance.
• Continued service is a condition for vesting, meaning any departure before the vesting date would result in forfeiture of these awards.

Future Outlook

The future outlook for the value of the granted RSUs and stock options is dependent on Arvinas, Inc.'s stock performance and the continued service of Director Laurie Smaldone Alsup.

Industry Context

StockSavvy.ai notes that the granting of stock options and RSUs to directors is a common practice in the biotechnology and pharmaceutical sectors, aligning executive compensation with long-term shareholder value and company performance.

Stakeholder Impact

• Shareholders: The equity grants align director incentives with shareholder interests, potentially leading to decisions that enhance stock value.
• Employees: The continued service requirement for vesting reinforces the importance of employee retention and performance.
• Management: The grants represent a form of compensation and incentive for the director.

Next Steps

• Vesting of RSUs and stock options on the earlier of June 24, 2027, or the first annual stockholders' meeting after the grant date, subject to continued service.
• Potential exercise of stock options by Laurie Smaldone Alsup after vesting.

Key Dates

Keywords

Arvinas, ARVN, Form 4, SEC Filing, Stock Options, Restricted Stock Units, RSU, Director Compensation, Equity Awards, Beneficial Ownership, Insider Trading